/C O R R E C T I O N -- BridGene Biosciences/
PR Newswire —
In the news release, BridGene Biosciences Raises $28 Million in Series B+ Financing to Accelerate Clinical Development of BGC-515 and Platform Expansion, issued 16-Oct-2025 by BridGene Biosciences over PR Newswire, we are advised by the company that the Bayland Capital boilerplate, has...